Literature DB >> 489760

Plasma level profiles and clinical response of penbutolol after three different single oral doses in man.

H W Jun, S L Hayes, J J Vallner, I L Honigberg, A E Rojos, J T Stewart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 489760     DOI: 10.1002/j.1552-4604.1979.tb02502.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  7 in total

1.  Penbutolol: pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand binding.

Authors:  D Brockmeier; P Hajdù; W Henke; E Mutschler; D Palm; W Rupp; H Spahn; M T Verho; A Wellstein
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Pharmacokinetics of penbutolol and its metabolites in renal insufficiency.

Authors:  N Bernard; G Cuisinaud; N Pozet; P Y Zech; J Sassard
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Penbutolol: beta-adrenoceptor interaction and the time course of plasma concentrations explain its prolonged duration of action in man.

Authors:  A Wellstein; D Palm
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Penbutolol (Hoe 893d) in primary hypertension. Blood pressure effects, tolerance and plasma concentrations.

Authors:  K P Ohman; J Asplund; S Landahl; B Liander
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Penbutolol: a preliminary review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

6.  Penbutolol Pharmacokinetics: the influence of concomitant administration of cimetidine.

Authors:  H Spahn; W Kirch; P Hajdu; E Mutschler; E E Ohnhaus
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Plasma protein binding of penbutolol in pregnancy.

Authors:  C Aquirre; J M Rodriguez-Sasiain; P Navajas; R Calvo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jan-Mar       Impact factor: 2.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.